Based on these findings, the authors suggested a tumor-suppressive role for omentin-1 in gastric cancer, acting through inhibition of PI3K/NF-κB signaling, restoration of HNF4α, and suppression of β-catenin activity. This evidence concerns the gene NFKB1 and neoplasm.